Author:
Yoshida Hideki,Koodie Lisa,Jacobsen Kari,Hanzawa Ken,Miyamoto Yasuhide,Yamamoto Masato
Abstract
Abstractβ-1,4-N-Acetyl-Galactosaminyltransferase 1 (B4GALNT1) encodes the key enzyme B4GALNT1 to generate gangliosides GM2/GD2. GM2/GD2 gangliosides are surface glycolipids mainly found on brain neurons as well as peripheral nerves and skin melanocytes and are reported to exacerbate the malignant potential of melanomas. In order to elucidate the mechanism, we performed functional analyses of B4GALNT1-overexpressing cells. We analyzed ganglioside pattern on four melanoma and two neuroblastoma cell lines by high performance liquid chromatography (HPLC). We overexpressed B4GALNT1 in GM2/GD2-negative human melanoma cell line (SH4) and confirmed production of GM2/GD2 by HPLC. They showed higher anchorage independence growth (AIG) in colony formation assay, and exhibited augmented motility. In vitro, cell proliferation was not affected by GM2/GD2 expression. In vivo, GM2/GD2-positive SH4 clones showed significantly higher tumorigenesis in NOD/Scid/IL2Rγ-null mice, and immunostaining of mouse CD31 revealed that GM2/GD2 induced remarkable angiogenesis. No differences were seen in melanoma stem cell and Epithelial-Mesenchymal Transition markers between GM2/GD2-positive and -negative SH4 cells. We therefore concluded that B4GALNT1, and consequently GM2/GD2, enhanced tumorigenesis via induction of angiogenesis, AIG, and cell motility. RNA-Seq suggested periostin as a potential key factor for angiogenesis and AIG. These findings may lead to development of novel therapy for refractory melanoma.
Publisher
Springer Science and Business Media LLC
Reference78 articles.
1. Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A. & Clarke, C. A. Increasing burden of melanoma in the United States. Journal of Investigative Dermatology 129, 1666–1674 (2009).
2. Erdei, E. & Torres, S. M. A new understanding in the epidemiology of melanoma. Expert review of anticancer therapy 10, 1811–1823 (2010).
3. Rigel, D. S. & Carucci, J. A. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA: a cancer journal for clinicians 50, 215–236 (2000).
4. Kosary, C. L., Altekruse, S. F., Ruhl, J., Lee, R. & Dickie, L. Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2. Cancer 120, 3807–3814 (2014).
5. Ernst, D. S. et al. Burden of illness for metastatic melanoma in Canada, 2011–2013. Current Oncology 23, e563 (2016).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献